Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China

NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

(2017) George D. Demetri et al.   Journal of the National Comprehensive Cancer Network

Knowns and Known Unknowns of Gastrointestinal Stromal Tumor Adjuvant Therapy

(2016) Virginia Martínez-Marín et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma

(2015) Xin-Ke Zhang et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Current management of gastrointestinal stromal tumors: Surgery, current biomarkers, mutations, and therapy

(2015) Nakul Valsangkar et al.   SURGERY

Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses

(2015) Geir Bredholt et al.   Oncotarget

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014)   ANNALS OF ONCOLOGY

Necrosis and apoptotic index as prognostic factors in non-small cell lung carcinoma: a review

(2014) Charalampos Gkogkou et al.   SpringerPlus

Gastrointestinal stromal tumour

(2013) Heikki Joensuu et al.   LANCET

SKP2 High Expression, KIT Exon 11 Deletions, and Gastrointestinal Bleeding as Predictors of Poor Prognosis in Primary Gastrointestinal Stromal Tumors

(2013) Ang Lv et al.   PLoS One

Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer

(2011) C. H. Richards et al.   BRITISH JOURNAL OF SURGERY

Closing in on accurate risk prediction and disease management for patients with operable GIST

(2011) Anette Duensing   LANCET ONCOLOGY

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts

(2011) Heikki Joensuu et al.   LANCET ONCOLOGY

Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation

(2010) N Hiraoka et al.   BRITISH JOURNAL OF CANCER

Adjuvant and neoadjuvant therapy for primary GIST

(2010) Burton L. Eisenberg et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Current Trends in the Epidemiological and Pathological Characteristics of Gastrointestinal Stromal Tumors in Korea, 2003-2004

(2010) Mee-Yon Cho et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Molecular mechanisms of late apoptotic/necrotic cell clearance

(2009) I K H Poon et al.   CELL DEATH AND DIFFERENTIATION

Mechanisms of Tumor Cell Necrosis

(2009) Sergey Proskuryakov et al.   CURRENT PHARMACEUTICAL DESIGN

Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract

(2009) Richard Zigeuner et al.   EUROPEAN UROLOGY

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

(2009) Ronald P DeMatteo et al.   LANCET

Which Is the Optimal Risk Stratification System for Surgically Treated Localized Primary GIST? Comparison of Three Contemporary Prognostic Criteria in 171 Tumors and a Proposal for a Modified Armed Forces Institute of Pathology Risk Criteria

(2008) Brian K. P. Goh et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical significance of oncogenicKITandPDGFRAmutations in gastrointestinal stromal tumours

(2008) J Lasota et al.   HISTOPATHOLOGY

Risk stratification of patients diagnosed with gastrointestinal stromal tumor

(2008) Heikki Joensuu   HUMAN PATHOLOGY

Prognostic Role of Histological Necrosis for Nonmetastatic Clear Cell Renal Cell Carcinoma: Correlation With Pathological Features and Molecular Markers

(2008) Andrea Minervini et al.   JOURNAL OF UROLOGY

Surgical Margin Status and Prognosis of Gastrointestinal Stromal Tumor

(2008) António M. Gouveia et al.   WORLD JOURNAL OF SURGERY